Medicare Enrolled
Dr. Christopher Diblasio, M.D.
Urology Physician · Bonita Springs, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Diblasio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Diblasio?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Diblasio
Dr. Christopher Diblasio is an urology physician in Bonita Springs, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Diblasio performed 3,094 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Diblasio received a total of $72,688 from 40 pharmaceutical and/or device companies across 219 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Diblasio is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 34% volume in FL
$72,688 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 152458 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗3,094
Medicare services
Top 34% in FL for urology physician
Not available
Unique patients (not deduplicated)
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
854 | $2 | $10 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
799 | $8 | $65 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
682 | $93 | $335 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
172 | $115 | $526 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
130 | $188 | $705 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
108 | $67 | $226 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 96 | $138 | $685 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
47 | $41 | $126 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
45 | $40 | $136 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
25 | $26 | $113 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
23 | $20 | $75 |
| Laser prostate fragmentation with bleeding control This procedure uses a laser to break up prostate tissue and control bleeding through an endoscope. |
22 | $684 | $3,338 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $79 | $342 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
22 | $69 | $325 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
19 | $73 | $1,600 |
| Prostate needle biopsy with image guidance A procedure to remove small tissue samples from the prostate gland using a needle. Image guidance is used to help the doctor accurately locate the area for sampling. |
15 | $285 | $1,270 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $100 | $431 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.6% high complexity
27.9% medium
71.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$72,688
Total received (2018-2024)
Avg $10,384/year across 7 years
Top 4% in FL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
219
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$52,809
2023
$5,547
2022
$3,493
2021
$370
2020
$1,435
2019
$6,714
2018
$2,319
Payments by company (2024)
Boston Scientific Corporation
$50,526
Profound Medical Corp.
$1,079
Axonics, Inc.
$202
Teleflex LLC
$171
Dendreon Pharmaceuticals LLC
$147
Janssen Biotech, Inc.
$139
Valencia Technologies Corporation
$115
Laborie Medical Technologies Corp.
$63
PROGENICS PHARMACEUTICALS, INC.
$59
Olympus America Inc.
$56
ABBVIE INC.
$48
AngioDynamics, Inc.
$37
IMMUNITYBIO, INC.
$31
Tolmar, Inc.
$25
Blue Earth Diagnostics Limited
$23
Myriad Genetic Laboratories, Inc.
$22
Merck Sharp & Dohme LLC
$22
FEMSelect Inc.
$16
Ferring Pharmaceuticals Inc.
$14
Endo USA, Inc.
$14
Top 3 companies account for 98.1% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$62,564
Teleflex LLC
$2,259
PROCEPT BioRobotics Corporation
$1,898
Profound Medical Corp.
$1,079
Valencia Technologies Corporation
$706
Janssen Biotech, Inc.
$483
Dendreon Pharmaceuticals LLC
$438
BOSTON SCIENTIFIC CORPORATION
$343
HealthTronics Mobile Solutions, LLC
$342
Palette Life Sciences, Inc.
$253
Axonics, Inc.
$243
Varian Medical Systems, Inc.
$197
Myriad Genetic Laboratories, Inc.
$196
NeoTract Inc.
$150
AngioDynamics, Inc.
$133
Laborie Medical Technologies Corp.
$126
Bayer Healthcare Pharmaceuticals Inc.
$119
Astellas Pharma US Inc
$112
Sumitomo Pharma America, Inc.
$107
Endo Pharmaceuticals Inc.
$96
Janssen Scientific Affairs, LLC
$86
Progenics Pharmaceuticals, Inc.
$86
Allergan, Inc.
$82
ABBVIE INC.
$66
PROGENICS PHARMACEUTICALS, INC.
$59
Olympus America Inc.
$56
Blue Earth Diagnostics Limited
$54
UROVANT SCIENCES INC
$52
Bayer HealthCare Pharmaceuticals Inc.
$45
AbbVie Inc.
$43
IMMUNITYBIO, INC.
$31
Tolmar, Inc.
$25
Telix Pharmaceuticals
$23
Novartis Pharmaceuticals Corporation
$23
UroGen Pharma, Inc.
$22
Merck Sharp & Dohme LLC
$22
Pacira Pharmaceuticals Incorporated
$21
FEMSelect Inc.
$16
Ferring Pharmaceuticals Inc.
$14
Endo USA, Inc.
$14
Top 3 companies account for 91.8% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AccuTrac · AquaBeam Robotic System · Axonics · Axumin · BOTOX · Bulkamid · ELIGARD · ENPLACE · ERLEADA · Endocare Cryocare System · Erleada · Exparel · Flexiva · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL THERAPIES · GENERAL - KIDNEY STONE DISEASE · GENERAL - THERAPIES · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GreenLight XPS · ILLUCCIX · JELMYTO · KEYTRUDA · LITHOVUE · LithoVue · Lumenis Pulse 120H · Mobile Cryoblation Services · Moses 550 DFL · NANOKNIFE · Nubeqa · OBTRYX · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolaris · SpaceOAR VUE System - 10mL · Tulsa-Pro · UROLIFT · UroLift · UroLift System · XIAFLEX · Xpeeda DSL Fiber · Xtandi · eCoin Device Kit · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
55
County median income
$73,099
Nearest hospital to ZIP centroid (approximate)
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
7.3 mi
7.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Diblasio is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Diblasio experienced with automated urinalysis?
Based on Medicare claims data, Dr. Diblasio performed 854 automated urinalysis services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Diblasio receive payments from pharmaceutical companies?
Yes. Dr. Diblasio received a total of $72,688 from 40 companies across 219 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Diblasio's costs compare to other urology physicians in Bonita Springs?
Dr. Diblasio's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Diblasio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Bonita Springs
Browse urology physicians in Bonita Springs ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology